Search Results
You are looking at 1 - 5 of 5 items for
- Author: Rong Huang x
- Refine by access: All content x
Search for other papers by Jiarui Wei in
Google Scholar
PubMed
Search for other papers by Xing Lan An in
Google Scholar
PubMed
Search for other papers by Cong Fu in
Google Scholar
PubMed
Search for other papers by Qi Li in
Google Scholar
PubMed
Search for other papers by Fang Wang in
Google Scholar
PubMed
Search for other papers by Rong Huang in
Google Scholar
PubMed
Search for other papers by Haibo Zhu in
Google Scholar
PubMed
Search for other papers by Ziyi Li in
Google Scholar
PubMed
Search for other papers by Sheng Zhang in
Google Scholar
PubMed
Thousands of genes are activated in late 2-cell embryos, which means that numerous pre-mRNAs are generated during this time. These pre-mRNAs must be accurately spliced to ensure that the mature mRNAs are translated to functional proteins. However, little is known about the roles of pre-mRNA splicing and cellular factors modulating pre-mRNA splicing during early embryonic development. Here, we report that downregulation of SON, a large Ser/Arg (SR)-related protein, reduced embryonic development and caused deficient blastomere cleavage. These embryonic developmental defects result from dysregulated nuclear speckle organization and pre-mRNA splicing of a set of cell cycle-related genes. Furthermore, SON downregulation disrupted the transcriptome (2128 upregulated and 1399 downregulated) in 4-cell embryos. Increased H3K4me3, H3K9me3 and H3K27me3 levels were detected in 4-cell embryos after SON downregulation. Taken together, these results demonstrate that accurate pre-mRNA splicing is essential for early embryonic development and that SON plays important roles in nuclear speckle organization, pre-mRNA splicing, transcriptome establishment and histone methylation reprogramming during early embryonic development.
Search for other papers by Shengxian Li in
Google Scholar
PubMed
Shanghai Key Laboratory for Assisted Reproduction and Reproductive Genetics, Shanghai, China
Search for other papers by Jia Qi in
Google Scholar
PubMed
Search for other papers by Yongzhen Tao in
Google Scholar
PubMed
Shanghai Key Laboratory for Assisted Reproduction and Reproductive Genetics, Shanghai, China
Search for other papers by Qinling Zhu in
Google Scholar
PubMed
Search for other papers by Rong Huang in
Google Scholar
PubMed
Search for other papers by Yu Liao in
Google Scholar
PubMed
Search for other papers by Jiang Yue in
Google Scholar
PubMed
Search for other papers by Wei Liu in
Google Scholar
PubMed
Shanghai Key Laboratory for Assisted Reproduction and Reproductive Genetics, Shanghai, China
Search for other papers by Hanting Zhao in
Google Scholar
PubMed
School of Life Science and Technology, ShanghaiTech University, Shanghai, China
Key Laboratory of Food Safety Risk Assessment, Ministry of Health, Beijing, China
Search for other papers by Huiyong Yin in
Google Scholar
PubMed
Shanghai Key Laboratory for Assisted Reproduction and Reproductive Genetics, Shanghai, China
Search for other papers by Yun Sun in
Google Scholar
PubMed
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in reproductive-age women usually accompanied by lipid metabolic disorders. However, it remains unknown whether arachidonic acid (AA) and its metabolites in follicular fluid (FF) were altered in PCOS patients. This study was intended to measure the levels of AA and its metabolites in the FF of non-obese PCOS patients that underwent in vitro fertilization (IVF) and to explore the possible causes of the alterations. Thirty-nine non-obese women with PCOS and 30 non-obese women without PCOS were enrolled. AA and its metabolites were measured by liquid chromatography-mass spectrometry. The levels of AA metabolites generated via cyclooxygenase-2 (COX-2) pathway and cytochrome P450 epoxygenase pathway but not lipoxygenase (LOX) pathway were significantly higher in the FF of PCOS patients. The metabolites generated via COX-2 pathway were significantly correlated with levels of testosterone and fasting insulin in serum. The in vitro study further demonstrated that insulin but not testosterone could promote the IL-1β and hCG-induced COX-2 expression and prostaglandin E2 (PGE2) secretion in primary human granulosa cells. In conclusion, there was an elevation in AA metabolites in FF of PCOS patients. Insulin played a pivotal role in the increased AA metabolites generated via COX-2, which could be interpreted as another novel molecular pathophysiological mechanism of PCOS.
Search for other papers by Yifan Feng in
Google Scholar
PubMed
Shanghai Key Laboratory for Assisted Reproduction and Reproductive Genetics, Shanghai, China
Search for other papers by Jia Qi in
Google Scholar
PubMed
School of Life Science and Technology, ShanghaiTech University, Shanghai, China
Key Laboratory of Food Safety Risk Assessment, Ministry of Health, Beijing, China
Search for other papers by Xinli Xue in
Google Scholar
PubMed
Shanghai Key Laboratory for Assisted Reproduction and Reproductive Genetics, Shanghai, China
Search for other papers by Xinyu Li in
Google Scholar
PubMed
Search for other papers by Yu Liao in
Google Scholar
PubMed
Shanghai Key Laboratory for Assisted Reproduction and Reproductive Genetics, Shanghai, China
Search for other papers by Yun Sun in
Google Scholar
PubMed
School of Life Science and Technology, ShanghaiTech University, Shanghai, China
Key Laboratory of Food Safety Risk Assessment, Ministry of Health, Beijing, China
Search for other papers by Yongzhen Tao in
Google Scholar
PubMed
School of Life Science and Technology, ShanghaiTech University, Shanghai, China
Key Laboratory of Food Safety Risk Assessment, Ministry of Health, Beijing, China
Search for other papers by Huiyong Yin in
Google Scholar
PubMed
Search for other papers by Wei Liu in
Google Scholar
PubMed
Search for other papers by Shengxian Li in
Google Scholar
PubMed
Search for other papers by Rong Huang in
Google Scholar
PubMed
In Brief
Polycystic ovary syndrome (PCOS) is a common cause of anovulatory infertility in women. This study identified changes in free fatty acids profiles in the follicular fluid that may lead to better diagnosis and management of infertility in PCOS women.
Abstract
Polycystic ovary syndrome (PCOS) is a heterogeneous disease characterized by various endocrine/metabolic disorders and impaired reproductive potential. Alterations in oocyte competence are considered potentially causative factors for infertility in PCOS women and analyzing the composition of follicular fluid in these patients may help to identify which changes have the potential to alter oocyte quality. In this study, free fatty acid metabolic signatures in follicular fluid were performed to identify changes that may impact oocyte competence in non-obese PCOS women. Sixty-four non-obese women (32 with PCOS and 32 age- and BMI-matched controls) undergoing in vitro fertilization were recruited. Embryo quality was morphologically assessed. Free fatty acid metabolic profiling in follicular fluid was performed using gas/liquid chromatography-mass spectrometry. Principal component analysis and orthogonal partial least squares-discriminant analysis models were further constructed. Nine free fatty acids and 24 eicosanoids were identified and several eicosanoids synthesized by the cyclooxygenase pathway were significantly elevated in PCOS patients compared to controls. The combination of PGE2, PGF2α, PGJ2, and TXB2 had an area under the curve of 0.867 (0.775–0.960) for PCOS discrimination. Furthermore, follicular fluid levels of PGE2 and PGJ2 were negatively correlated with high-quality embryo rate in PCOS patients (P < 0.05). Metabolomic analysis revealed that follicular fluid lipidomic profiles undergo changes in non-obese PCOS women, which suggests that identifying changes in important metabolic signatures may give us a better understanding of the pathogenesis of PCOS. Furthermore, elevated PGE2 and PGJ2 concentrations may contribute to impaired oocyte competence in non-obese PCOS patients.
Key Laboratory of Assisted Reproduction, Ministry of Education, Beijing, China
Beijing Key Laboratory of Reproductive Endocrinology and Assisted Reproductive Technology, Beijing, China
Search for other papers by Ying Huang in
Google Scholar
PubMed
Beijing Key Laboratory of Reproductive Endocrinology and Assisted Reproductive Technology, Beijing, China
Search for other papers by Jiang-Man Gao in
Google Scholar
PubMed
Key Laboratory of Assisted Reproduction, Ministry of Education, Beijing, China
Search for other papers by Chun-Mei Zhang in
Google Scholar
PubMed
Beijing Key Laboratory of Reproductive Endocrinology and Assisted Reproductive Technology, Beijing, China
Search for other papers by Hong-Cui Zhao in
Google Scholar
PubMed
Key Laboratory of Assisted Reproduction, Ministry of Education, Beijing, China
Search for other papers by Yue Zhao in
Google Scholar
PubMed
Beijing Key Laboratory of Reproductive Endocrinology and Assisted Reproductive Technology, Beijing, China
Search for other papers by Rong Li in
Google Scholar
PubMed
Key Laboratory of Assisted Reproduction, Ministry of Education, Beijing, China
Beijing Key Laboratory of Reproductive Endocrinology and Assisted Reproductive Technology, Beijing, China
Search for other papers by Yang Yu in
Google Scholar
PubMed
Key Laboratory of Assisted Reproduction, Ministry of Education, Beijing, China
Beijing Key Laboratory of Reproductive Endocrinology and Assisted Reproductive Technology, Beijing, China
Search for other papers by Jie Qiao in
Google Scholar
PubMed
Polycystic ovary syndrome (PCOS) is a common reproductive disorder that has many characteristic features including hyperandrogenemia, insulin resistance and obesity, which may have significant implications for pregnancy outcomes and long-term health of women. Daughters born to PCOS mothers constitute a high-risk group for metabolic and reproductive derangements, but no report has described potential growth and metabolic risk factors for such female offspring. Hence, we used a mouse model of dehydroepiandrosterone (DHEA)-induced PCOS to study the mechanisms underlying the pathology of PCOS by investigating the growth, developmental characteristics, metabolic indexes and expression profiles of key genes of offspring born to the models. We found that the average litter size was significantly smaller in the DHEA group, and female offspring had sustained higher body weight, increased body fat and triglyceride content in serum and liver; they also exhibited decreased energy expenditure, oxygen consumption and impaired glucose tolerance. Genes related to glucolipid metabolism such as Pparγ, Acot1/2, Fgf21, Pdk4 and Inhbb were upregulated in the liver of the offspring in DHEA group compared with those in controls, whereas Cyp17a1 expression was significantly decreased. However, the expression of these genes was not detected in male offspring. Our results show that female offspring in DHEA group exhibit perturbed growth and glucolipid metabolism that were not observed in male offspring.
Search for other papers by Xue-Ying Zhang in
Google Scholar
PubMed
Search for other papers by Yi-Meng Xiong in
Google Scholar
PubMed
Search for other papers by Ya-Jing Tan in
Google Scholar
PubMed
Search for other papers by Li Wang in
Google Scholar
PubMed
Search for other papers by Rong Li in
Google Scholar
PubMed
Search for other papers by Yong Zhang in
Google Scholar
PubMed
Search for other papers by Xin-Mei Liu in
Google Scholar
PubMed
Search for other papers by Xian-Hua Lin in
Google Scholar
PubMed
Search for other papers by Li Jin in
Google Scholar
PubMed
Search for other papers by Yu-Ting Hu in
Google Scholar
PubMed
Search for other papers by Zhen-Hua Tang in
Google Scholar
PubMed
Search for other papers by Zheng-Mu Wu in
Google Scholar
PubMed
Search for other papers by Feng-Hua Yin in
Google Scholar
PubMed
Search for other papers by Zheng-Quan Wang in
Google Scholar
PubMed
Search for other papers by Ye Xiao in
Google Scholar
PubMed
Department of Pathology and Pathophysiology, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China
Search for other papers by Jian-Zhong Sheng in
Google Scholar
PubMed
The International Peace Maternity and Child Health Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
Shanghai Key Laboratory of Embryo Original Diseases, Shanghai, China
Search for other papers by He-Feng Huang in
Google Scholar
PubMed
Fertilization failure often occurs during in vitro fertilization (IVF) cycles despite apparently normal sperm and oocytes. Accumulating evidence suggests that mitochondria play crucial roles in the regulation of sperm function and male fertility. 3-Nitrophthalic acid (3-NPA) can induce oxidative stress in mitochondria, and melatonin, as an antioxidant, can improve mitochondrial function by reducing mitochondrial oxidative stress. The role of sperm mitochondrial dysfunction in fertilization failure during IVF is unclear. The present study revealed that spermatozoa with low, or poor, fertilization rates had swollen mitochondria, increased mitochondria-derived ROS, and attenuated mitochondrial respiratory capacity. 3-NPA treatment enhanced mitochondrial dysfunction in sperm. Spermatozoa with poor fertilization rates, and spermatozoa treated with 3-NPA, had reduced penetration ability. The concentration of melatonin was decreased in semen samples with low and poor fertilization rates. Melatonin, not only decreased excessive mitochondria-derived ROS, but also ‘rescued’ the reduced penetration capacity of spermatozoa treated with 3-NPA. Taken together, the study suggested that mitochondria-derived ROS and mitochondrial respiratory capacity are independent bio-markers for sperm dysfunction, and melatonin may be useful in improving sperm quality and overall male fertility.
